Cargando…
Characterization of HIV-1 Nucleoside-Modified mRNA Vaccines in Rabbits and Rhesus Macaques
Despite the enormous effort in the development of effective vaccines against HIV-1, no vaccine candidate has elicited broadly neutralizing antibodies in humans. Thus, generation of more effective anti-HIV vaccines is critically needed. Here we characterize the immune responses induced by nucleoside-...
Autores principales: | Pardi, Norbert, LaBranche, Celia C., Ferrari, Guido, Cain, Derek W., Tombácz, István, Parks, Robert J., Muramatsu, Hiromi, Mui, Barbara L., Tam, Ying K., Karikó, Katalin, Polacino, Patricia, Barbosa, Christopher J., Madden, Thomas D., Hope, Michael J., Haynes, Barton F., Montefiori, David C., Hu, Shiu-Lok, Weissman, Drew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6454128/ https://www.ncbi.nlm.nih.gov/pubmed/30974332 http://dx.doi.org/10.1016/j.omtn.2019.03.003 |
Ejemplares similares
-
Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses
por: Pardi, Norbert, et al.
Publicado: (2018) -
Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies
por: Pardi, Norbert, et al.
Publicado: (2018) -
Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA
por: Karikó, Katalin, et al.
Publicado: (2011) -
Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge
por: Pardi, Norbert, et al.
Publicado: (2017) -
Nucleoside-modified VEGFC mRNA induces organ-specific lymphatic growth and reverses experimental lymphedema
por: Szőke, Dániel, et al.
Publicado: (2021)